 CAMBRIDGE, Mass. and GOSSELIES, Belgium, Jan. 05, 2021 GLOBE NEWSWIRE -- iTeos Therapeutics, Inc. Nasdaq: ITOS, a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will present a company overview at the 39th Annual J.P. Morgan Conference, being held virtually on Tuesday, January 12, 2021 at 9:10 a.m. ET. 